ATG5 as biomarker for early detection of malignant mesothelioma

ATG5 as biomarker for early detection of malignant mesothelioma

Abstract Objectives Malignant pleural mesothelioma (MPM) is an aggressive disease with grim prognosis due to lack of effective treatment options. Disease prediction in association with early diagnosis may both contribute to improved MPM survival. Inflammation and autophagy are two processes associat...

Full description

Bibliographic Details
Main Authors: Marco Tomasetti, Federica Monaco, Olga Strogovets, Luca Volpini, Matteo Valentino, Monica Amati, Jiri Neuzil, Lory Santarelli
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Research Notes
Subjects:
Asbestos exposure
Malignant pleural mesothelioma
ATG5
HMGB1
miRNAs
Biomarkers
Online Access:https://doi.org/10.1186/s13104-023-06330-1

Internet

https://doi.org/10.1186/s13104-023-06330-1

Similar Items